September 30, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Biotech firm Arcutis gets $94.5M in funding round

IN THIS ARTICLE

Westlake Village dermatology therapy startup Arcutis announced a $94.5 million capital raise Oct. 21 to fund Phase 3 clinical development for its topical plaque psoriasis treatment. The financing round was led by HBM Healthcare Investments and included funding from Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures and Goldman Sachs. Returning investors also contributed to the…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.